Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

PURPOSE: The Standardized Definitions for Efficacy End Points (STEEP) criteria, established in 2007 and updated in 2021 (STEEP 2.0), provide standardized definitions of adjuvant breast cancer (BC) end points. STEEP 2.0 identified a need to separately address end points for neoadjuvant clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Litton, Jennifer K., Regan, Meredith M., Pusztai, Lajos, Rugo, Hope S., Tolaney, Sara M., Garrett-Mayer, Elizabeth, Amiri-Kordestani, Laleh, Basho, Reva K., Best, Ana F., Boileau, Jean-Francois, Denkert, Carsten, Foster, Jared C., Harbeck, Nadia, Jacene, Heather A., King, Tari A., Mason, Ginny, O'Sullivan, Ciara C., Prowell, Tatiana M., Richardson, Andrea L., Sepulveda, Karla A., Smith, Mary Lou, Tjoe, Judy A., Turashvili, Gulisa, Woodward, Wendy A., Butler, Lynn Pearson, Schwartz, Elena I., Korde, Larissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Special Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522109/
https://www.ncbi.nlm.nih.gov/pubmed/37433103
http://dx.doi.org/10.1200/JCO.23.00435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522109/
https://www.ncbi.nlm.nih.gov/pubmed/37433103
http://dx.doi.org/10.1200/JCO.23.00435

Ejemplares similares